Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation

Clinical trial NCT04322890 · RECRUITING

Trial details

NCT number: NCT04322890
Sponsor: Hunan Province Tumor Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer EGFR Gene Mutation ALK Gene Mutation ROS1 Gene Mutation MET Gene Mutation

Start date: 2020-04-16
Primary completion: 2026-12-24
Enrollment: 6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.